抑制PCSK9对人类葡萄糖代谢和β细胞功能的影响:试点研究
Simona Moffa1, Teresa Mezza1,2, Pietro Manuel Ferraro3
1Centro Malattie Endocrine e Metaboliche, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Frontiers in endocrinology
|June 16, 2023
概括
在一项试点研究中,抗PCSK9单克隆抗体改善了胰腺β细胞功能. 这种疗法增强了葡萄糖敏感性,但没有影响葡萄糖水平,特别是在体重指数和胰岛素耐药性较高的患者中.
科学领域:
- 心血管研究研究心血管研究
- 代谢障碍 代谢障碍 代谢障碍
- 药理学 药理学是指药理学的学科.
背景情况:
- 反PCSK9单克隆抗体有效降低LDL-C和心血管事件.
- PCSK9在胰腺中表达,PCSK9淘汰小鼠显示胰岛素分泌受损.
- 已知他类药物会影响胰岛素分泌,这促使人们对PCSK9抑制剂进行研究.
研究的目的:
- 评估抗PCSK9单克隆抗体 (mAb) 治疗对人类葡萄糖代谢和β细胞功能的影响.
- 评估葡萄糖耐受性,胰岛素分泌和胰岛素敏感性的变化.
- 探索治疗效果与患者特征 (如BMI和胰岛素抵抗) 之间的相关性.
主要方法:
- 一项试点研究涉及15名接受抗PCSK9 mAb治疗的非糖尿病患者.
- 在基线和6个月后进行了口服葡萄糖耐受性测试 (OGTT).
- 用C-解卷计算β细胞葡萄糖敏感度,用马苏达指数评估胰岛素敏感度.
主要成果:
- 在OGTT期间,抗PCSK9 mAb治疗没有改变葡萄糖,胰岛素或C-水平.
- 松田胰岛素敏感性指数保持不变.
- 治疗后β细胞的葡萄糖敏感性显著改善 (p<0.05),特别是在BMI较高和胰岛素耐药性较高的患者中.
结论:
- 六个月的抗PCSK9 mAb治疗可以改善β细胞功能,但不会影响葡萄糖耐受性.
- 观察到的β细胞功能的改善在BMI和胰岛素耐药性较高的个体中更为明显.
- 这项试点研究表明,抗PCSK9 mAb对胰腺β细胞功能有潜在的有益作用.
相关概念视频
Dipeptidyl Peptidase 4 Inhibitors
216
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
216
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.3K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.3K
Cell Specific Gene Expression
13.6K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.6K
Hormones Regulating Blood Glucose
3.6K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.6K
Glucose Homeostasis: Regulation of Blood Glucose
1.8K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
1.8K
Oral Hypoglycemic Agents: Biguanides and Glitazones
240
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
240


